Max Seibold
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 44 | 2023 | 2029 | 4.700 |
Why?
| Respiratory Mucosa | 13 | 2020 | 251 | 3.870 |
Why?
| Transcriptome | 10 | 2022 | 726 | 2.900 |
Why?
| Interleukin-13 | 10 | 2023 | 122 | 2.420 |
Why?
| Gene Expression Profiling | 16 | 2020 | 1518 | 2.150 |
Why?
| Nasal Mucosa | 7 | 2023 | 93 | 1.960 |
Why?
| Epithelial Cells | 12 | 2023 | 951 | 1.820 |
Why?
| Mucin 5AC | 5 | 2022 | 48 | 1.490 |
Why?
| Hypersensitivity | 4 | 2022 | 252 | 1.350 |
Why?
| Lung | 13 | 2023 | 3561 | 1.110 |
Why?
| Polymorphism, Single Nucleotide | 17 | 2022 | 1880 | 1.050 |
Why?
| Mucin-5B | 5 | 2020 | 183 | 1.030 |
Why?
| Genetic Predisposition to Disease | 14 | 2019 | 2086 | 1.010 |
Why?
| Th2 Cells | 6 | 2023 | 154 | 0.960 |
Why?
| Epithelium | 3 | 2023 | 295 | 0.880 |
Why?
| Single-Cell Analysis | 4 | 2021 | 189 | 0.850 |
Why?
| Hexosaminidases | 2 | 2016 | 17 | 0.830 |
Why?
| Interferons | 2 | 2020 | 151 | 0.830 |
Why?
| Particulate Matter | 2 | 2021 | 185 | 0.800 |
Why?
| Idiopathic Pulmonary Fibrosis | 5 | 2020 | 505 | 0.770 |
Why?
| Sequence Analysis, RNA | 8 | 2021 | 386 | 0.760 |
Why?
| Peptidyl-Dipeptidase A | 2 | 2021 | 51 | 0.760 |
Why?
| Enterovirus Infections | 2 | 2023 | 160 | 0.710 |
Why?
| Trachea | 2 | 2020 | 224 | 0.710 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 439 | 0.710 |
Why?
| Serine Endopeptidases | 1 | 2020 | 102 | 0.690 |
Why?
| Gene Expression Regulation | 9 | 2023 | 2320 | 0.680 |
Why?
| Respiratory Tract Infections | 3 | 2020 | 319 | 0.660 |
Why?
| Quantitative Trait Loci | 3 | 2020 | 305 | 0.650 |
Why?
| Alveolar Epithelial Cells | 2 | 2018 | 93 | 0.650 |
Why?
| Pneumonia, Viral | 2 | 2020 | 338 | 0.620 |
Why?
| Coronavirus Infections | 2 | 2020 | 330 | 0.620 |
Why?
| Smoking | 2 | 2020 | 1383 | 0.610 |
Why?
| Betacoronavirus | 2 | 2020 | 250 | 0.610 |
Why?
| Dermatitis, Atopic | 5 | 2019 | 307 | 0.610 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 3 | 2019 | 22 | 0.610 |
Why?
| Genome, Human | 2 | 2018 | 347 | 0.610 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 916 | 0.610 |
Why?
| STAT6 Transcription Factor | 1 | 2018 | 22 | 0.600 |
Why?
| Bronchodilator Agents | 5 | 2023 | 239 | 0.600 |
Why?
| Host-Pathogen Interactions | 2 | 2020 | 295 | 0.600 |
Why?
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 51 | 0.590 |
Why?
| Humans | 74 | 2023 | 114705 | 0.590 |
Why?
| Cadherins | 1 | 2019 | 175 | 0.590 |
Why?
| Gene Editing | 1 | 2018 | 57 | 0.570 |
Why?
| CRISPR-Cas Systems | 1 | 2018 | 78 | 0.560 |
Why?
| RNA Virus Infections | 1 | 2017 | 11 | 0.550 |
Why?
| RNA Viruses | 1 | 2017 | 28 | 0.540 |
Why?
| Gene Deletion | 1 | 2018 | 356 | 0.520 |
Why?
| Amides | 1 | 2016 | 86 | 0.520 |
Why?
| Lectins | 1 | 2016 | 42 | 0.510 |
Why?
| Adipokines | 1 | 2016 | 42 | 0.510 |
Why?
| Steroids | 1 | 2016 | 144 | 0.490 |
Why?
| Genome-Wide Association Study | 8 | 2023 | 1177 | 0.490 |
Why?
| Inflammation | 7 | 2023 | 2480 | 0.480 |
Why?
| Child | 25 | 2023 | 18420 | 0.470 |
Why?
| Pulmonary Fibrosis | 2 | 2023 | 323 | 0.460 |
Why?
| Forced Expiratory Volume | 5 | 2020 | 475 | 0.450 |
Why?
| Membrane Proteins | 2 | 2020 | 1019 | 0.450 |
Why?
| Case-Control Studies | 12 | 2020 | 3003 | 0.450 |
Why?
| Pyridines | 1 | 2016 | 425 | 0.420 |
Why?
| Air Pollution | 3 | 2020 | 169 | 0.410 |
Why?
| Adrenal Cortex Hormones | 5 | 2021 | 497 | 0.410 |
Why?
| Chitinases | 2 | 2009 | 8 | 0.410 |
Why?
| Stem Cells | 1 | 2016 | 546 | 0.400 |
Why?
| Haplotypes | 3 | 2011 | 448 | 0.390 |
Why?
| Gene Expression | 7 | 2023 | 1421 | 0.390 |
Why?
| Bronchi | 5 | 2020 | 232 | 0.380 |
Why?
| Animals | 22 | 2023 | 31709 | 0.380 |
Why?
| Metaplasia | 2 | 2022 | 54 | 0.380 |
Why?
| Lung Diseases | 1 | 2018 | 701 | 0.370 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2011 | 58 | 0.370 |
Why?
| Picornaviridae Infections | 2 | 2023 | 29 | 0.370 |
Why?
| Mucus | 2 | 2022 | 54 | 0.370 |
Why?
| Cells, Cultured | 7 | 2020 | 3886 | 0.350 |
Why?
| Mice | 16 | 2023 | 14872 | 0.350 |
Why?
| Mexican Americans | 3 | 2022 | 101 | 0.350 |
Why?
| Allergens | 4 | 2021 | 413 | 0.350 |
Why?
| Male | 37 | 2021 | 55607 | 0.330 |
Why?
| Cell Differentiation | 6 | 2018 | 1701 | 0.320 |
Why?
| Genotype | 8 | 2019 | 1760 | 0.320 |
Why?
| Gene-Environment Interaction | 3 | 2020 | 183 | 0.310 |
Why?
| Female | 37 | 2021 | 59521 | 0.310 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 9 | 0.310 |
Why?
| NIH 3T3 Cells | 2 | 2020 | 137 | 0.300 |
Why?
| Genomics | 3 | 2018 | 635 | 0.300 |
Why?
| Linkage Disequilibrium | 6 | 2020 | 245 | 0.300 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2022 | 287 | 0.290 |
Why?
| Cellular Reprogramming | 2 | 2020 | 84 | 0.290 |
Why?
| Sputum | 5 | 2023 | 286 | 0.290 |
Why?
| DNA Methylation | 3 | 2023 | 495 | 0.290 |
Why?
| Minority Groups | 3 | 2022 | 227 | 0.280 |
Why?
| Genetic Variation | 4 | 2020 | 870 | 0.270 |
Why?
| Interleukin-33 | 2 | 2016 | 38 | 0.260 |
Why?
| Polymorphism, Genetic | 3 | 2016 | 610 | 0.260 |
Why?
| Adolescent | 20 | 2022 | 17853 | 0.260 |
Why?
| Adult | 23 | 2022 | 30553 | 0.260 |
Why?
| Cilia | 2 | 2020 | 162 | 0.260 |
Why?
| Lung Diseases, Interstitial | 1 | 2011 | 508 | 0.250 |
Why?
| Immunity, Innate | 2 | 2021 | 720 | 0.250 |
Why?
| Transcription Factors | 4 | 2023 | 1528 | 0.240 |
Why?
| Cell Culture Techniques | 2 | 2018 | 343 | 0.240 |
Why?
| Skin | 2 | 2019 | 655 | 0.230 |
Why?
| Middle Aged | 15 | 2021 | 26738 | 0.230 |
Why?
| Genetic Association Studies | 2 | 2016 | 339 | 0.230 |
Why?
| Pandemics | 3 | 2021 | 1320 | 0.230 |
Why?
| Albuterol | 3 | 2023 | 102 | 0.230 |
Why?
| Environmental Exposure | 3 | 2017 | 372 | 0.230 |
Why?
| Puerto Rico | 5 | 2020 | 51 | 0.220 |
Why?
| Helminthiasis | 1 | 2023 | 10 | 0.220 |
Why?
| Rhinovirus | 2 | 2023 | 40 | 0.210 |
Why?
| Chemokine CCL5 | 1 | 2023 | 45 | 0.210 |
Why?
| Epigenesis, Genetic | 3 | 2023 | 521 | 0.210 |
Why?
| Nasal Polyps | 1 | 2023 | 49 | 0.200 |
Why?
| Pulmonary Surfactants | 1 | 2023 | 99 | 0.200 |
Why?
| Salmeterol Xinafoate | 1 | 2021 | 41 | 0.190 |
Why?
| Cystic Fibrosis | 2 | 2022 | 955 | 0.190 |
Why?
| Biomarkers | 4 | 2022 | 3408 | 0.190 |
Why?
| Surgical Tape | 2 | 2019 | 3 | 0.190 |
Why?
| Fluticasone | 1 | 2021 | 87 | 0.190 |
Why?
| Macrophages, Alveolar | 2 | 2019 | 348 | 0.190 |
Why?
| Strongylida Infections | 1 | 2021 | 6 | 0.190 |
Why?
| Gene Regulatory Networks | 2 | 2020 | 228 | 0.190 |
Why?
| Rhinitis | 1 | 2023 | 128 | 0.190 |
Why?
| Down-Regulation | 2 | 2021 | 594 | 0.190 |
Why?
| Pharmacogenomic Testing | 1 | 2021 | 53 | 0.190 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2020 | 24 | 0.180 |
Why?
| Interleukin-4 | 2 | 2020 | 206 | 0.180 |
Why?
| Sinusitis | 1 | 2023 | 174 | 0.180 |
Why?
| Gene Frequency | 3 | 2011 | 477 | 0.180 |
Why?
| Virus Internalization | 1 | 2020 | 40 | 0.180 |
Why?
| Signal Transduction | 5 | 2020 | 4516 | 0.180 |
Why?
| Epidermis | 2 | 2019 | 149 | 0.180 |
Why?
| fas Receptor | 1 | 2020 | 91 | 0.180 |
Why?
| Keratinocytes | 2 | 2018 | 216 | 0.180 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2020 | 67 | 0.180 |
Why?
| Stem Cell Factor | 1 | 2020 | 14 | 0.180 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 98 | 0.170 |
Why?
| Clinical Decision-Making | 1 | 2022 | 268 | 0.170 |
Why?
| Neutrophils | 3 | 2023 | 1176 | 0.170 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2020 | 91 | 0.170 |
Why?
| Air Pollutants | 2 | 2020 | 242 | 0.170 |
Why?
| Coronavirus | 1 | 2020 | 40 | 0.170 |
Why?
| Lymphocytes | 1 | 2021 | 330 | 0.160 |
Why?
| Smokers | 1 | 2020 | 129 | 0.160 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 100 | 0.160 |
Why?
| Young Adult | 12 | 2021 | 10471 | 0.160 |
Why?
| Biological Transport | 1 | 2020 | 374 | 0.160 |
Why?
| Cadherin Related Proteins | 1 | 2019 | 12 | 0.160 |
Why?
| Interleukin-1 Receptor-Associated Kinases | 1 | 2019 | 20 | 0.160 |
Why?
| Immunologic Memory | 1 | 2021 | 313 | 0.160 |
Why?
| Dendritic Cells | 2 | 2019 | 435 | 0.160 |
Why?
| CD11c Antigen | 1 | 2019 | 38 | 0.160 |
Why?
| Cytokines | 4 | 2023 | 1841 | 0.160 |
Why?
| Cell Line | 5 | 2020 | 2637 | 0.160 |
Why?
| Eczema | 1 | 2019 | 81 | 0.160 |
Why?
| Clone Cells | 2 | 2016 | 247 | 0.160 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2018 | 10 | 0.160 |
Why?
| Pharmacogenetics | 2 | 2010 | 149 | 0.160 |
Why?
| Smad2 Protein | 1 | 2018 | 33 | 0.160 |
Why?
| Lung Neoplasms | 2 | 2023 | 2177 | 0.150 |
Why?
| Receptors, Odorant | 1 | 2018 | 35 | 0.150 |
Why?
| Enterovirus | 1 | 2019 | 72 | 0.150 |
Why?
| Pharmacogenomic Variants | 1 | 2018 | 33 | 0.150 |
Why?
| Acetyltransferases | 1 | 2018 | 20 | 0.150 |
Why?
| Airway Remodeling | 1 | 2018 | 57 | 0.150 |
Why?
| Eosinophilia | 1 | 2020 | 186 | 0.150 |
Why?
| Molecular Sequence Annotation | 1 | 2018 | 81 | 0.150 |
Why?
| Sequence Analysis, DNA | 2 | 2018 | 723 | 0.140 |
Why?
| Glycoproteins | 1 | 2019 | 304 | 0.140 |
Why?
| Epigenomics | 2 | 2023 | 101 | 0.140 |
Why?
| Phosphoproteins | 1 | 2019 | 298 | 0.140 |
Why?
| Cell-Matrix Junctions | 1 | 2016 | 2 | 0.140 |
Why?
| Cockroaches | 1 | 2016 | 21 | 0.130 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 388 | 0.130 |
Why?
| Gene Expression Regulation, Viral | 1 | 2017 | 80 | 0.130 |
Why?
| Culture Media | 1 | 2016 | 155 | 0.130 |
Why?
| Nose | 1 | 2016 | 55 | 0.130 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 83 | 0.130 |
Why?
| Risk Factors | 5 | 2022 | 8632 | 0.130 |
Why?
| Fibroblasts | 2 | 2020 | 838 | 0.130 |
Why?
| Data Interpretation, Statistical | 1 | 2018 | 321 | 0.130 |
Why?
| Bronchiolitis, Viral | 1 | 2015 | 10 | 0.130 |
Why?
| In Vitro Techniques | 1 | 2018 | 1016 | 0.130 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 39 | 0.130 |
Why?
| Respiratory Function Tests | 3 | 2016 | 522 | 0.130 |
Why?
| Urban Population | 2 | 2016 | 397 | 0.130 |
Why?
| Influenza, Human | 1 | 2021 | 546 | 0.130 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2021 | 959 | 0.120 |
Why?
| Genomic Imprinting | 1 | 2015 | 32 | 0.120 |
Why?
| Genetic Testing | 1 | 2018 | 381 | 0.120 |
Why?
| Indians, North American | 1 | 2020 | 570 | 0.120 |
Why?
| Lipid Metabolism | 1 | 2018 | 444 | 0.120 |
Why?
| Homeodomain Proteins | 1 | 2018 | 463 | 0.120 |
Why?
| Cell Communication | 1 | 2016 | 280 | 0.120 |
Why?
| Administration, Inhalation | 4 | 2021 | 641 | 0.120 |
Why?
| Alternative Splicing | 1 | 2016 | 187 | 0.120 |
Why?
| Food Hypersensitivity | 1 | 2019 | 251 | 0.120 |
Why?
| Pulmonary Emphysema | 1 | 2017 | 272 | 0.120 |
Why?
| Eosinophils | 3 | 2023 | 278 | 0.120 |
Why?
| Up-Regulation | 2 | 2018 | 808 | 0.120 |
Why?
| Computational Biology | 1 | 2018 | 530 | 0.110 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 688 | 0.110 |
Why?
| Software | 1 | 2018 | 530 | 0.110 |
Why?
| Prospective Studies | 2 | 2022 | 6220 | 0.110 |
Why?
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 14 | 0.110 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 104 | 0.110 |
Why?
| Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.110 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 590 | 0.100 |
Why?
| Exons | 1 | 2014 | 302 | 0.100 |
Why?
| Receptors, Purinergic P2X7 | 1 | 2012 | 11 | 0.100 |
Why?
| Islets of Langerhans | 1 | 2019 | 726 | 0.100 |
Why?
| Extracellular Matrix | 1 | 2016 | 436 | 0.100 |
Why?
| Lipids | 3 | 2023 | 580 | 0.100 |
Why?
| Cysts | 1 | 2013 | 93 | 0.100 |
Why?
| RNA, Small Interfering | 3 | 2019 | 535 | 0.100 |
Why?
| Dinoprostone | 2 | 2023 | 184 | 0.100 |
Why?
| Phenotype | 3 | 2014 | 2797 | 0.100 |
Why?
| Recombinant Proteins | 2 | 2019 | 1230 | 0.100 |
Why?
| Precision Medicine | 1 | 2015 | 337 | 0.090 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 4694 | 0.090 |
Why?
| Microscopy, Fluorescence | 1 | 2013 | 396 | 0.090 |
Why?
| T-Lymphocytes | 1 | 2019 | 1737 | 0.090 |
Why?
| Chromosome Mapping | 3 | 2020 | 487 | 0.090 |
Why?
| Beclomethasone | 1 | 2010 | 25 | 0.090 |
Why?
| Anaphylaxis | 1 | 2013 | 143 | 0.090 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2010 | 28 | 0.090 |
Why?
| United States | 8 | 2021 | 12186 | 0.090 |
Why?
| Promoter Regions, Genetic | 2 | 2013 | 1131 | 0.090 |
Why?
| Genetic Linkage | 1 | 2011 | 294 | 0.090 |
Why?
| Intestines | 1 | 2013 | 326 | 0.090 |
Why?
| Alleles | 3 | 2019 | 789 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 270 | 0.090 |
Why?
| Antigens, Bacterial | 1 | 2010 | 112 | 0.090 |
Why?
| Mice, Knockout | 3 | 2021 | 2570 | 0.080 |
Why?
| Peanut Hypersensitivity | 1 | 2013 | 197 | 0.080 |
Why?
| Vital Capacity | 1 | 2010 | 255 | 0.080 |
Why?
| Disaccharides | 1 | 2009 | 16 | 0.080 |
Why?
| Genetic Loci | 1 | 2011 | 262 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2021 | 3535 | 0.080 |
Why?
| Environmental Pollutants | 1 | 2011 | 110 | 0.080 |
Why?
| RNA | 2 | 2013 | 809 | 0.080 |
Why?
| Insecta | 1 | 2009 | 64 | 0.080 |
Why?
| Mexico | 1 | 2009 | 162 | 0.080 |
Why?
| Disease Susceptibility | 1 | 2010 | 316 | 0.080 |
Why?
| San Francisco | 1 | 2008 | 54 | 0.080 |
Why?
| Substrate Specificity | 1 | 2009 | 352 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 283 | 0.080 |
Why?
| Catalysis | 1 | 2009 | 289 | 0.080 |
Why?
| Primary Cell Culture | 2 | 2019 | 150 | 0.070 |
Why?
| Molecular Structure | 1 | 2009 | 434 | 0.070 |
Why?
| Sex Factors | 2 | 2015 | 1715 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 1 | 2009 | 511 | 0.070 |
Why?
| Odds Ratio | 3 | 2016 | 953 | 0.070 |
Why?
| Child, Preschool | 6 | 2020 | 9118 | 0.070 |
Why?
| Antiviral Agents | 2 | 2023 | 645 | 0.070 |
Why?
| S100 Proteins | 2 | 2018 | 38 | 0.070 |
Why?
| Monocytes | 2 | 2021 | 504 | 0.070 |
Why?
| Protein Structure, Tertiary | 1 | 2009 | 796 | 0.070 |
Why?
| Obesity | 1 | 2019 | 2508 | 0.070 |
Why?
| Aged | 6 | 2019 | 19074 | 0.070 |
Why?
| Keratins | 2 | 2019 | 176 | 0.070 |
Why?
| Mucins | 2 | 2018 | 61 | 0.060 |
Why?
| Binding Sites | 1 | 2009 | 1168 | 0.060 |
Why?
| Kinetics | 1 | 2009 | 1551 | 0.060 |
Why?
| Phylogeny | 1 | 2009 | 789 | 0.060 |
Why?
| Demography | 2 | 2020 | 260 | 0.060 |
Why?
| Severity of Illness Index | 3 | 2019 | 2540 | 0.060 |
Why?
| Homeostasis | 2 | 2020 | 573 | 0.060 |
Why?
| Genetic Markers | 2 | 2018 | 320 | 0.050 |
Why?
| Socioeconomic Factors | 3 | 2016 | 1079 | 0.050 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3252 | 0.050 |
Why?
| Axonemal Dyneins | 1 | 2022 | 8 | 0.050 |
Why?
| Th1 Cells | 1 | 2023 | 123 | 0.050 |
Why?
| Interleukin-17 | 1 | 2023 | 104 | 0.050 |
Why?
| Chemokines | 1 | 2023 | 216 | 0.050 |
Why?
| Nippostrongylus | 1 | 2021 | 3 | 0.050 |
Why?
| Alternaria | 1 | 2021 | 8 | 0.050 |
Why?
| Bronchoalveolar Lavage | 1 | 2021 | 84 | 0.050 |
Why?
| Respiratory System | 1 | 2022 | 137 | 0.050 |
Why?
| Afghanistan | 1 | 2021 | 108 | 0.050 |
Why?
| Adoptive Transfer | 1 | 2021 | 195 | 0.040 |
Why?
| Cohort Studies | 3 | 2020 | 4895 | 0.040 |
Why?
| Esophageal Mucosa | 1 | 2020 | 17 | 0.040 |
Why?
| Mutation | 1 | 2011 | 3346 | 0.040 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2020 | 20 | 0.040 |
Why?
| Chromatin Immunoprecipitation | 1 | 2020 | 128 | 0.040 |
Why?
| Fibrosis | 1 | 2022 | 453 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 94 | 0.040 |
Why?
| Interleukin-5 | 1 | 2020 | 30 | 0.040 |
Why?
| Dominican Republic | 1 | 2019 | 18 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 740 | 0.040 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 309 | 0.040 |
Why?
| Chemokine CCL26 | 1 | 2019 | 7 | 0.040 |
Why?
| Water Loss, Insensible | 1 | 2019 | 2 | 0.040 |
Why?
| Bleomycin | 1 | 2020 | 228 | 0.040 |
Why?
| Eugenol | 1 | 2018 | 3 | 0.040 |
Why?
| Arginase | 1 | 2019 | 27 | 0.040 |
Why?
| Acetophenones | 1 | 2018 | 14 | 0.040 |
Why?
| Intermediate Filament Proteins | 1 | 2019 | 65 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 951 | 0.040 |
Why?
| Lymph Nodes | 1 | 2021 | 419 | 0.040 |
Why?
| Myocytes, Smooth Muscle | 1 | 2020 | 236 | 0.040 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2019 | 157 | 0.040 |
Why?
| Lipopolysaccharide Receptors | 1 | 2019 | 81 | 0.040 |
Why?
| Neutrophil Activation | 1 | 2019 | 94 | 0.040 |
Why?
| Infant | 3 | 2020 | 7964 | 0.040 |
Why?
| Immunomodulation | 1 | 2019 | 84 | 0.040 |
Why?
| Area Under Curve | 1 | 2019 | 274 | 0.040 |
Why?
| Genes, T-Cell Receptor | 1 | 2018 | 6 | 0.040 |
Why?
| Genes, Immunoglobulin | 1 | 2018 | 26 | 0.040 |
Why?
| Receptors, Immunologic | 1 | 2019 | 201 | 0.040 |
Why?
| Disease Progression | 2 | 2016 | 2380 | 0.040 |
Why?
| Smell | 1 | 2018 | 111 | 0.040 |
Why?
| Gene Ontology | 1 | 2017 | 46 | 0.040 |
Why?
| Linear Models | 2 | 2010 | 768 | 0.040 |
Why?
| Epistasis, Genetic | 1 | 2017 | 67 | 0.040 |
Why?
| Spirometry | 1 | 2017 | 224 | 0.030 |
Why?
| Flow Cytometry | 1 | 2020 | 1083 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2019 | 555 | 0.030 |
Why?
| Chronic Disease | 1 | 2023 | 1578 | 0.030 |
Why?
| Membrane Glycoproteins | 1 | 2019 | 430 | 0.030 |
Why?
| Treatment Outcome | 3 | 2020 | 9088 | 0.030 |
Why?
| Geography, Medical | 1 | 2016 | 10 | 0.030 |
Why?
| Adenosine Triphosphate | 1 | 2018 | 430 | 0.030 |
Why?
| Macrophages | 1 | 2023 | 1263 | 0.030 |
Why?
| Basophils | 1 | 2016 | 64 | 0.030 |
Why?
| Reproducibility of Results | 2 | 2015 | 2765 | 0.030 |
Why?
| Public Health Surveillance | 1 | 2016 | 61 | 0.030 |
Why?
| CD56 Antigen | 1 | 2015 | 34 | 0.030 |
Why?
| Base Sequence | 1 | 2019 | 2114 | 0.030 |
Why?
| Respiratory Syncytial Viruses | 1 | 2015 | 46 | 0.030 |
Why?
| Mast Cells | 1 | 2016 | 116 | 0.030 |
Why?
| Databases, Nucleic Acid | 1 | 2015 | 31 | 0.030 |
Why?
| Morbidity | 1 | 2016 | 280 | 0.030 |
Why?
| Logistic Models | 1 | 2020 | 1841 | 0.030 |
Why?
| Nitric Oxide | 1 | 2020 | 823 | 0.030 |
Why?
| Exome | 1 | 2015 | 200 | 0.030 |
Why?
| Organ Specificity | 1 | 2015 | 268 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 1036 | 0.030 |
Why?
| Tetraspanin 24 | 1 | 2013 | 5 | 0.030 |
Why?
| Integrin alpha6 | 1 | 2013 | 8 | 0.030 |
Why?
| Immunization | 1 | 2016 | 397 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 455 | 0.030 |
Why?
| Pneumonia | 1 | 2019 | 568 | 0.030 |
Why?
| Thromboplastin | 1 | 2013 | 71 | 0.030 |
Why?
| Th17 Cells | 1 | 2013 | 58 | 0.030 |
Why?
| Nuclear Pore | 1 | 2012 | 14 | 0.030 |
Why?
| Aldehyde Dehydrogenase | 1 | 2013 | 102 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2018 | 1950 | 0.030 |
Why?
| Age Factors | 1 | 2020 | 2894 | 0.030 |
Why?
| Gene Silencing | 1 | 2013 | 171 | 0.030 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 127 | 0.030 |
Why?
| Regeneration | 1 | 2013 | 160 | 0.020 |
Why?
| Adenocarcinoma | 1 | 2018 | 795 | 0.020 |
Why?
| Bacteria | 1 | 2018 | 725 | 0.020 |
Why?
| Prednisone | 1 | 2012 | 229 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2018 | 2711 | 0.020 |
Why?
| Microbiota | 1 | 2019 | 647 | 0.020 |
Why?
| Cell Lineage | 1 | 2013 | 309 | 0.020 |
Why?
| RNA Interference | 1 | 2013 | 433 | 0.020 |
Why?
| Enzyme Activation | 1 | 2013 | 785 | 0.020 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 17 | 0.020 |
Why?
| Algorithms | 1 | 2018 | 1470 | 0.020 |
Why?
| Risk | 1 | 2013 | 812 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2011 | 157 | 0.020 |
Why?
| Survival Analysis | 1 | 2013 | 1211 | 0.020 |
Why?
| Receptors, Interleukin-6 | 1 | 2009 | 34 | 0.020 |
Why?
| Saliva | 1 | 2010 | 188 | 0.020 |
Why?
| Reference Values | 1 | 2010 | 743 | 0.020 |
Why?
| Suburban Population | 1 | 2008 | 16 | 0.020 |
Why?
| Michigan | 1 | 2008 | 96 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2018 | 4410 | 0.020 |
Why?
| Risk Assessment | 1 | 2016 | 2968 | 0.020 |
Why?
| Immunoglobulin E | 1 | 2008 | 314 | 0.020 |
Why?
| Emigration and Immigration | 1 | 2007 | 44 | 0.020 |
Why?
| Acculturation | 1 | 2007 | 50 | 0.020 |
Why?
| Cell Proliferation | 1 | 2013 | 2187 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2553 | 0.020 |
Why?
| Interleukin-6 | 1 | 2009 | 676 | 0.020 |
Why?
| Environment | 1 | 2007 | 332 | 0.020 |
Why?
| Prognosis | 1 | 2010 | 3330 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2010 | 6347 | 0.010 |
Why?
| Infant, Newborn | 1 | 2008 | 5047 | 0.010 |
Why?
| Pregnancy | 1 | 2008 | 5520 | 0.010 |
Why?
| Retrospective Studies | 1 | 2013 | 12556 | 0.010 |
Why?
|
|
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|